Whole Genomes
31000
Whole Genomes

Translational Genomics

At QGP, we seek to utilize whole genome sequencing with other omics data to facilitate the translation of basic science research discoveries into clinical precision medicine practices more quickly and efficiently.

expand or contract icon
Returning Genomic Information

QGP started a project on reporting wellness and lifestyle traits based on analyzing whole genome sequencing data of QBB participants. Wellness and lifestyle reports include 29 different traits related to body weight, response to diet and eating behavior, food reactions, exercise, and metabolic health factors.

expand or contract icon
Pharmacogenomics

Pharmacogenomics (PGx) uses an individual’s genetic information to identify the right drug at the right dose at the right time. PGx information can maximize the therapeutic efficacy of the medications and prevent adverse drug reactions by identifying how specific genetic variations might affect individual responses to medications.

expand or contract icon
Clinical Alliance

The team is working closely with different clinical units at governmental hospitals and health centers to facilitate and co-ordinate clinical collaborative studies to ensure the achievement of quality research outcomes and integrate precision medicine into the healthcare system in Qatar.

expand or contract icon
QChip

Qatar Genome and Qatar Biobank partnered with the Department of Genetic Medicine at Weill Cornell Medicine-Qatar , the Diagnostic Genomic Division at Hamad Medical Corporation as well as the Sidra research team at Sidra Medicine to facilitate the development of the first Qatari gene chip, known as the ‘Q-Chip’.

expand or contract icon
Pan Arab Array

Coming Soon

QGP started a project on reporting wellness and lifestyle traits based on analyzing whole genome sequencing data of QBB participants. Wellness and lifestyle reports include 29 different traits related to body weight, response to diet and eating behavior, food reactions, exercise, and metabolic health factors.

Pharmacogenomics (PGx) uses an individual’s genetic information to identify the right drug at the right dose at the right time. PGx information can maximize the therapeutic efficacy of the medications and prevent adverse drug reactions by identifying how specific genetic variations might affect individual responses to medications.

The team is working closely with different clinical units at governmental hospitals and health centers to facilitate and co-ordinate clinical collaborative studies to ensure the achievement of quality research outcomes and integrate precision medicine into the healthcare system in Qatar.

Qatar Genome and Qatar Biobank partnered with the Department of Genetic Medicine at Weill Cornell Medicine-Qatar , the Diagnostic Genomic Division at Hamad Medical Corporation as well as the Sidra research team at Sidra Medicine to facilitate the development of the first Qatari gene chip, known as the ‘Q-Chip’.

Coming Soon

Videos

Genome Heroes Stories

قصة2 - مجتمع صحي - علم الوراثة

قصة3 - رقاقة جينية

قصة 4 - انتقال الصفات الوراثية

قصة5 - رحلة إلى نواة الحياة الصفات اختلاف الصفات الوراثية

قصة6 - نزهة علمية الجينات تحدد الصفات

قصة7 - علم الجينوم في رحلة إلى نواة الحياة

قصة 10 - فيروس كورونا

قصة 11 - مستقبل دراسة الجينوم

قصة 12 - التوحد

قصة 14 - قصة الجينوم وعلوم الحاسوب

Genome Heroes Games

News

20/07/2020

Why does COVID-19 kill some and not others, global study…

Qatar Genome is the first and only active participant from an Arab country in the COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic…

07/09/2019

The Summer Programme at Msheireb Museums Wraps Up with a…

7 September 2019, Doha, Qatar- Qatar Genome and Qatar Biobank held a workshop for children and their parents, at Msheireb Museums, entitled: Genome World! During the workshop,…

17/04/2019

QATAR GENOME PROGRAMME JOINS FORCES WITH GENOMICS ENGLAND

MoU strengthens research capacity to provide new medical insights into genomics

27/03/2019

QATAR GENOME PROGRAMME SHOWCASES PROGRESS AT ROYAL SOCIETY…

Event held as part of ‘100,000 Genomes Project’ celebrations

20/02/2019

QNRF AND QGP LAUNCH THIRD CYCLE OF ‘PATH TOWARDS PRECISION…

QF members support the realization of precision medicine in Qatar Doha, Qatar, February 20, 2019: Qatar Genome Programme (QGP) and Qatar National Research Fund (QNRF),…

13/11/2018

Qatar Genome and Qatar Biobank Lead Efforts to Produce the…

QATAR GENOME AND BIOBANK LEAD EFFORTS TO PRODUCE FIRST QATARI GENE CHIP Nov 13, 2018: Her Highness Sheikha Moza was presented with the first 'Q-chip', during WISH Summit,…

25/08/2018

Qatar Genome embarked on a research collaboration with the…

Doha, Qatar – August 26, 2018: Qatar Genome Programme (QGP), a member of Qatar Foundation (QF), has embarked on a research collaboration with the Qatar Cardiovascular…

29/04/2018

With More Than 1200 participants Qatar Genome Holds its…

Doha, April 29, 2018: Qatar Genome Programme (QGP), a member of Qatar Foundation (QF), welcomed more than 1,200 healthcare providers, researchers, and experts to its second…

10/10/2017

QGP SURVEYS FIND PUBLIC SUPPORT FOR INITIATIVE

Two surveys on Qatar Genome Programme (QGP) have found widespread willingness among the local population to participate in the initiative, which seeks to map the Qatari genome…

03/09/2017

The Path Towards Precision Medicine PPM Awards are Announced

  The awards for the second cycle of PPM, the research awards co-funded by Qatar Genome Programme QGP and Qatar National Research Fund QNRF were announced in Doha, during…

23/08/2017

Genome Interpretation Internship for Healthcare…

Qatar Genome Programme (QGP) concluded its third annual summer internship recently, entitled ‘Genome Interpretation: from Sequencing to Counseling’. It was attended by a group of…

12/03/2017

"Qatar is bringing precision medicine to their population,…

FrontLine Genomics Magazine featured Qatar Genome Program in its February Issue under the title: " BUILDING A GLOBAL MAP OF GENOMICS". Explaining the important role Qatar…